National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
The discipline of infectious diseases will assume added prominence in the 21st century in both developed and developing nations. To an unprecedented extent, issues related to infectious diseases in the context of global health are on the agendas of world leaders, health policymakers, and philanthropies. This attention has focused both on scientific challenges such as vaccine development and on the deleterious effects of infectious diseases on economic development and political stability. Interest in global health has led to increasing levels of financial support, which, combined with recent technological advances, provide extraordinary opportunities for infectious disease research in the 21st century. The sequencing of human and microbial genomes and advances in functional genomics will underpin significant progress in many areas, including understanding human predisposition and susceptibility to disease, microbial pathogenesis, and the development new diagnostics, vaccines, and therapies. Increasingly, infectious disease research will be linked to the development of the medical infrastructure and training needed in developing countries to translate scientific advances into operational reality.
Cited by
A. R. ZANETTI, A. ZAPPA. (2010) Emerging and re-emerging infections at the turn of the millennium.
Haemophilia 16, 7-12
Online publication date: 1-Feb-2010.
CrossRef Eduardo Ruiz-Hitzky, Margarita Darder, Pilar Aranda, M. Ángeles Martín del Burgo, Gustavo del Real. (2009) Bionanocomposites as New Carriers for Influenza Vaccines.
Advanced Materials 21:41, 4167-4171
Online publication date: 6-Dec-2009.
CrossRef Yanming Zou, Lina He, Feng Chi, Ambrose Jong, Sheng-He Huang. (2009) Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.
Medical Microbiology and Immunology 197:4, 337-344
Online publication date: 1-Jan-2009.
CrossRef M. Tariq Bhatti. (2008) Optic Neuropathy From Viruses and Spirochetes.
International Ophthalmology Clinics 47:4, 37-66
Online publication date: 1-Dec-2008.
CrossRef Lalit Kant. (2008) Combating emerging infectious diseases in India: Orchestrating a symphony.
Journal of Biosciences 33:4, 425-427
Online publication date: 1-Dec-2008.
CrossRef Xiaonan Yang, Hongliang Yang, Gangqiao Zhou, Guo-Ping Zhao. (2008) Infectious Disease in the Genomic Era.
Annual Review of Genomics and Human Genetics 9:1, 21-48
Online publication date: 1-Oct-2008.
CrossRef Brad Spellberg. (2008) Dr. William H. Stewart: Mistaken or Maligned?.
Clinical Infectious Diseases 47:2, 294-294
Online publication date: 15-Jul-2008.
Brad Spellberg, Robert Guidos, David Gilbert, John Bradley, Helen W. Boucher, W. Michael Scheld, John G. Bartlett, and John Edwards, Jr., for the Infectious Diseases Society of America. (2008) The Epidemic of Antibiotic‐Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America.
Clinical Infectious Diseases 46:2, 155-164
Online publication date: 15-Jan-2008.
Anthony S Fauci. (2007) The expanding global health agenda: a welcome development.
Nature Medicine 13:10, 1169-1171
Online publication date: 1-Nov-2007.
CrossRef Sheng-He Huang, Xiaoning Wang, Ambrose Jong. (2007) The evolving role of infectomics in drug discovery.
Expert Opinion on Drug Discovery 2:7, 961-975
Online publication date: 1-Aug-2007.
CrossRef Claude G. Lerner, Philip J. Hajduk, Rolf Wagner, Frank L. Wagenaar, Charlotte Woodall, Yu-Gui Gu, Xenia B. Searle, Alan S. Florjancic, Tianyuan Zhang, Richard F. Clark, Curt S. Cooper, Jamey C. Mack, Liping Yu, Mengli Cai, Steven F. Betz, Linda E. Chovan, J. Owen McCall, Candace L. Black-Schaefer, Stephan J. Kakavas, Mark E. Schurdak, Kenneth M. Comess, Karl A. Walter, Rohinton Edalji, Sarah A. Dorwin, Richard A. Smith, Eric J. Hebert, John E. Harlan, Randy E. Metzger, Philip J. Merta, John L. Baranowski, Michael L. Coen, Susan J. Thornewell, Annapur G. Shivakumar, Anne Y. Saiki, Niru Soni, Mai Bui, Darlene J. Balli, William J. Sanders, Angela M. Nilius, Thomas F. Holzman, Stephen W. Fesik, Bruce A. Beutel. (2007) From Bacterial Genomes to Novel Antibacterial Agents: Discovery, Characterization, and Antibacterial Activity of Compounds that Bind to HI0065 (YjeE) from Haemophilus influenzae.
Chemical Biology & Drug Design 69:6, 395-404
Online publication date: 1-Jul-2007.
CrossRef Andreas Hornung, Marcelo Bertazzo, Agnieszka Dziarnowski, Kathrin Schneider, Katrin Welzel, Sven-Eric Wohlert, Meike Holzenkämpfer, Graeme J. Nicholson, Andreas Bechthold, Roderich D. Süssmuth, Andreas Vente, Stefan Pelzer. (2007) A Genomic Screening Approach to the Structure-Guided Identification of Drug Candidates from Natural Sources.
ChemBioChem 8:7, 757-766
Online publication date: 7-Jun-2007.
CrossRef Carlos Franco-Paredes, Nadine Rouphael, José Méndez, Erik Folch, Alfonso J. Rodraíguez-Morales, José Ignacio Santos, J. W. Hurst. (2007) Cardiac manifestations of parasitic infections part 1: Overview and immunopathogenesis.
Clinical Cardiology 30:4, 195-199
Online publication date: 1-May-2007.
CrossRef Paul Yager, Thayne Edwards, Elain Fu, Kristen Helton, Kjell Nelson, Milton R. Tam, Bernhard H. Weigl. (2006) Microfluidic diagnostic technologies for global public health.
Nature 442:7101, 412-418
Online publication date: 27-Aug-2006.
CrossRef Hiroshi YONEYAMA, Ryoichi KATSUMATA. (2006) Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development.
Bioscience, Biotechnology, and Biochemistry 70:5, 1060-1075
Online publication date: 1-Feb-2006.
CrossRef Anthony S. Fauci. (2006) Emerging and Reemerging Infectious Diseases: The Perpetual Challenge.
Academic Medicine 80:12, 1079-1085
Online publication date: 1-Jan-2006.
CrossRef Gino C. Matibag, Manabu Igarashi, Ron E. Porte, Hiko Tamashiro. (2005) Advocacy, promotion and e-learning: Supercourse for zoonosis.
Environmental Health and Preventive Medicine 10:5, 273-281
Online publication date: 1-Oct-2005.
CrossRef Brian C Monk, David R K Harding. (2005) Peptide Motifs for Cell-Surface Intervention.
BioDrugs 19:4, 261-278
Online publication date: 1-Feb-2005.
CrossRef David M. Morens, Gregory K. Folkers, Anthony S. Fauci. (2004) The challenge of emerging and re-emerging infectious diseases.
Nature 430:6996, 242-249
Online publication date: 8-Aug-2004.
CrossRef Carlos Franco‐Paredes and José Ignacio Santos. (2003) Parasitology Resources on the World Wide Web: A Powerful Tool for Infectious Disease Practitioners.
Clinical Infectious Diseases 37:5, 694-701
Online publication date: 1-Sep-2003.
Robert J Zagursky, Stephen B Olmsted, David P Russell, Joe L Wooters. (2003) Bioinformatics: how it is being used to identify bacterial vaccine candidates.
Expert Review of Vaccines 2:3, 417-436
Online publication date: 1-Jul-2003.
CrossRef D. C. Knockaert, S. Vanderschueren, D. Blockmans. (2003) Fever of unknown origin in adults: 40 years on.
Journal of Internal Medicine 253:3, 263-275
Online publication date: 1-Apr-2003.
CrossRef Tim Ibbotson, Caroline M Perry. (2003) Lamivudine/Zidovudine/Abacavir.
Drugs 63:11, 1089-1098
Online publication date: 1-Feb-2003.
CrossRef Richard Daifuku. (2003) Stealth Nucleosides.
BioDrugs 17:3, 169-177
Online publication date: 1-Feb-2003.
CrossRef Judith Feinberg and Anthony J. Japour. (2003) Scientific and Ethical Considerations in Trial Design for Investigational Agents for the Treatment of Human Immunodeficiency Virus Infection.
Clinical Infectious Diseases 36:2, 201-206
Online publication date: 15-Jan-2003.
Thomas Dandekar, Rainer Sauerborn. (2002) Comparative genome analysis and pathway reconstruction.
Pharmacogenomics 3:2, 245-256
Online publication date: 1-Apr-2002.
CrossRef A Alloueche, G Del Giudice, R Rappuoli. Disease Eradication by Vaccination: Prospects. .
CrossRef Sheng-He Huang, Bai-Lian Li, Hong Cao. Infectomics: Study of Microbial Infections Using Omic Approaches. .
CrossRef